Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site/version update and does not change the study details shown on the record.SummaryDifference0.0%

- Check17 days agoChange DetectedCollaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd and the document revision advanced from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedUpdated the revision label to v3.5.0 and removed the previous v3.4.3 entry.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded the NEJM 2021 CheckMate 577 publication citation; removed the Erratum reference.SummaryDifference0.0%

- Check82 days agoChange DetectedA new revision label v3.4.2 was added to the study documents, replacing the previous v3.4.1.SummaryDifference0.0%

- Check89 days agoChange DetectedAdded the CheckMate 577 NEJM publication entry with full author list and erratum citation; removed the previous NEJM entry and updated the revision from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.